870244-34-1

Basic information

• Product Name: 3,5-Dibromo-4-cyanopyridine, 97%
• Synonyms: 3,5-Dibromo-4-cyanopyridine, 97%;4-Cyano-3,5 dibroMopyridine;3,5-dibroMopyridine-4-carbonitrile;3,5-dibroMo-isonicotinonitrile;4-Pyridinecarbonitrile, 3,5-dibroMo-;3,5-Dibromopyridine-4-carbonitrile 97%;3,5-dibromo-4-Pyridinecarbonitrile;3,5-dibromoisonicotinonitrile C6H2Br2N2 261.90
• CAS NO: 870244-34-1
• Molecular Formula: C₆H₂Br₂N₂
• Molecular Weight: 261.91
• Mol File: 870244-34-1.mol
• Article Data: 3

Chemical Properties

• Melting Point: 149-151°C
• Boiling Point: 317.6 °C at 760 mmHg
• Flash Point: 145.9 °C
• Appearance: /
• Density: 2.19g/cm³
• Vapor Pressure: 0.00038mmHg at 25°C
• Refractive Index: 1.67
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: -2.85±0.28(Predicted)
• CAS DataBase Reference: 3,5-Dibromo-4-cyanopyridine, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-Dibromo-4-cyanopyridine, 97%(870244-34-1)
• EPA Substance Registry System: 3,5-Dibromo-4-cyanopyridine, 97%(870244-34-1)

Safety Data

• Hazard Codes: T
• Statements: 25-41-43
• Safety Statements: 26-36/37/39-45
• RIDADR: UN3439
• WGK Germany: 3
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 870244-34-1(Hazardous Substances Data)

Usage

General Description

3,5-Dibromo-4-cyanopyridine is a chemical compound that is 97% pure. It is a cyanopyridine derivative with two bromine atoms and a cyano group attached to the pyridine ring. 3,5-Dibromo-4-cyanopyridine, 97% is commonly used as a building block in organic synthesis and is often utilized in the pharmaceutical industry for the production of various drugs and pharmaceutical intermediates. It is soluble in organic solvents and has a wide range of applications in chemical research and manufacturing processes. This high-purity chemical is important for researchers and industries requiring accurate and consistent results in their experiments and production processes.

InChI:InChI=1/C6H2Br2N2/c7-5-2-10-3-6(8)4(5)1-9/h2-3H

Upstream product

• 625-92-3 3,5-dibromopyridine 
• 70201-42-2 3,5-dibromopyridine-4-carboxaldehyde 

Downstream Products

• 870244-35-2 4-bromo-1H-pyrazolo[3,4-c]pyridin-3-amine 
• 1357945-96-0 7-bromo-1H-pyrazolo[4,3-c]pyridin-3-amine 
• 1572517-04-4 3-amino-N-(2-(4-methoxyphenyl)cyclopropyl)-4-methylthieno[2,3-c]pyridine-2-carboxamide 
• 1572517-05-5 3-amino-N-(2-(4-methoxyphenyl)cyclopropyl)-4-methylthieno[2,3-c]pyridine-2-carboxamide 
• 1572517-01-1 3-amino-N-(2-( 4-methoxyphenyl)cyclopropyl)-4-methylthieno[2,3-c]pyridine-2-carboxamide 
• 1446357-61-4 3,5-dibromoisonicotinamide 
• 1446357-47-6 5-bromo-2-(4-methoxyphenyl)-4H-pyrido[4,3-e][1,3]oxazin-4-one 
• 1446393-82-3 sodium (3,5-dibromoisonicotinoyl)(4-methoxybenzoyl)amide 
• 1446357-46-5 5-bromo-2-(3-methoxyphenyl)-4H-pyrido[4,3-e][1,3]oxazin-4-one 
• 1446393-81-2 sodium (3,5-dibromoisonicotinoyl)(3-methoxybenzoyl)amide 
• 1446357-45-4 5-bromo-2-phenyl-4H-pyrido[4,3-e][1,3]oxazin-4-one 
• 1446393-80-1 sodium benzoyl(3,5-dibromoisonicotinoyl)amide 
• 1404367-14-1 3-bromo-5-cyclopropylisonicotinonitrile 

Relevant articles and documents

NAPHTHYLUREA DERIVATIVES AND MEDICAL APPLICATIONS THEREOF

The present invention relates to naphthylurea derivatives. Such substances can significantly inhibit VEGFR2 and PDGFR-β receptor tyrosine kinase phosphorylation at nanomolar concentration levels. It is a novel type of tyrosine kinase inhibitors which can be used in the treatment of tyrosine kinase-mediated diseases or symptoms such as malignancies and ocular diseases accompanied with pathologic neovascularization

An efficient catalytic method for the Beckmann rearrangement of ketoximes to amides and aldoximes to nitriles mediated by propylphosphonic anhydride (T3P)

An efficient method for the Beckmann rearrangement of ketoximes to amides mediated by a catalytic amount (15 mol %) of propylphosphonic anhydride (T3P) is described. Aldoximes underwent second order Beckmann rearrangement to provide the corresponding nitriles in excellent yields on reacting with T3P (15 mol %) at room temperature. The main advantages of this environmentally friendly protocol include procedural simplicity, and particularly ease of isolation of the products.